These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria. van Ingen J, Boeree MJ, van Soolingen D, Mouton JW. Drug Resist Updat; 2012 Jun; 15(3):149-61. PubMed ID: 22525524 [Abstract] [Full Text] [Related]
8. Pulmonary Non-tuberculous Mycobacterial Infections in Category II Failures from National Tuberculosis Programme. Dholakia YN, Shah DP. Indian J Chest Dis Allied Sci; 2015 Jun; 57(1):27-30. PubMed ID: 26410980 [Abstract] [Full Text] [Related]
9. Simultaneous detection of Mycobacterium tuberculosis complex and nontuberculous mycobacteria in respiratory specimens. Hwang SM, Lim MS, Hong YJ, Kim TS, Park KU, Song J, Lee JH, Kim EC. Tuberculosis (Edinb); 2013 Nov; 93(6):642-6. PubMed ID: 23988279 [Abstract] [Full Text] [Related]
10. Increasing Prevalence of Nontuberculous Mycobacteria in Respiratory Specimens from US-Affiliated Pacific Island Jurisdictions1. Lin C, Russell C, Soll B, Chow D, Bamrah S, Brostrom R, Kim W, Scott J, Bankowski MJ. Emerg Infect Dis; 2018 Mar; 24(3):485-491. PubMed ID: 29460734 [Abstract] [Full Text] [Related]
11. Management of nontuberculous mycobacterial (NTM) lung disease. Philley JV, Griffith DE. Semin Respir Crit Care Med; 2013 Feb; 34(1):135-42. PubMed ID: 23460013 [Abstract] [Full Text] [Related]
12. Paradigm for diagnosing mycobacterial disease: direct detection and differentiation of Mycobacterium tuberculosis complex and non-tuberculous mycobacteria in clinical specimens using multiplex real-time PCR. Kim JU, Ryu DS, Cha CH, Park SH. J Clin Pathol; 2018 Sep; 71(9):774-780. PubMed ID: 29559518 [Abstract] [Full Text] [Related]
13. A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease. Lyu J, Kim BJ, Kim BJ, Song JW, Choi CM, Oh YM, Lee SD, Kim WS, Kim DS, Shim TS. Respir Med; 2014 Nov; 108(11):1706-12. PubMed ID: 25245792 [Abstract] [Full Text] [Related]
14. Non-tuberculous mycobacteria profiles and their anti-mycobacterial resistance at a major medical center in Lebanon. Araj GF, Baba OZ, Itani LY, Avedissian AZ, Sobh GM. J Infect Dev Ctries; 2019 Jul 31; 13(7):612-618. PubMed ID: 32065818 [Abstract] [Full Text] [Related]
15. Clinical significance and antibiotic susceptibilities of nontuberculous mycobacteria from patients in Crete, Greece. Gitti Z, Mantadakis E, Maraki S, Samonis G. Future Microbiol; 2011 Sep 31; 6(9):1099-109. PubMed ID: 21958147 [Abstract] [Full Text] [Related]
16. Laboratory aspects of clinically significant rapidly growing mycobacteria. Set R, Shastri J. Indian J Med Microbiol; 2011 Sep 31; 29(4):343-52. PubMed ID: 22120792 [Abstract] [Full Text] [Related]
17. Human infections due to nontuberculous mycobacteria: the infectious diseases and clinical microbiology specialists' point of view. Guglielmetti L, Mougari F, Lopes A, Raskine L, Cambau E. Future Microbiol; 2015 Sep 31; 10(9):1467-83. PubMed ID: 26344005 [Abstract] [Full Text] [Related]
18. Identification and drug susceptibility testing for nontuberculous mycobacteria. Huang WC, Yu MC, Huang YW. J Formos Med Assoc; 2020 Jun 31; 119 Suppl 1():S32-S41. PubMed ID: 32423573 [Abstract] [Full Text] [Related]
19. Culture, Identification, and Antimicrobial Susceptibility Testing of Pulmonary Nontuberculous Mycobacteria. Khare R, Brown-Elliott BA. Clin Chest Med; 2023 Dec 31; 44(4):743-755. PubMed ID: 37890913 [Abstract] [Full Text] [Related]
20. Antimicrobial susceptibility and MIC distribution of 41 drugs against clinical isolates from China and reference strains of nontuberculous mycobacteria. Li G, Pang H, Guo Q, Huang M, Tan Y, Li C, Wei J, Xia Y, Jiang Y, Zhao X, Liu H, Zhao LL, Liu Z, Xu D, Wan K. Int J Antimicrob Agents; 2017 Mar 31; 49(3):364-374. PubMed ID: 28131606 [Abstract] [Full Text] [Related] Page: [Next] [New Search]